Schlusskurs
Andere Börsenplätze
|
% 5 Tage | % 1. Jan. | ||
89.6 BDT | 0.00% |
|
-1.43% | +6.16% |
Kurzporträt
Mitarbeiterzahl: 4 143
Umsatz nach Geschäftsbereich
BDT in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Human Health
80,9
%
| 4 553 | 81,6 % | 5 388 | 80,9 % | +18.36% |
Veterinary
19,1
%
| 1 030 | 18,4 % | 1 270 | 19,1 % | +23.30% |
Umsatz je Region
BDT in Millionen | 2022 | Gewichtung | 2023 | Gewichtung | Delta |
---|---|---|---|---|---|
Bangladesh
100,0
%
| 4 759 | 100,0 % | 5 706 | 100,0 % | +19.91% |
Manager
Manager | Titel | Alter | Seit |
---|---|---|---|
Mohammad Shafiq
CEO | Chief Executive Officer | 63 | 25.11.20 |
Director of Finance/CFO | 42 | 25.03.13 | |
Director of Finance/CFO | 54 | 25.11.20 | |
Chief Administrative Officer | 44 | 07.04.13 | |
Malay Kumar Dey
CTO | Chief Tech/Sci/R&D Officer | 39 | 15.11.20 |
Shamim Rabbani
COO | Chief Operating Officer | 64 | 01.10.20 |
Sayeed Ahmed
BRD | Director/Board Member | 46 | 25.11.20 |
Sanjoy Banik
PRN | Corporate Officer/Principal | 49 | 01.07.14 |
Corporate Officer/Principal | 56 | 04.10.20 | |
Corporate Officer/Principal | 44 | 04.10.20 |
Aufsichtsräte
Aufsichtsräte | Titel | Alter | Seit |
---|---|---|---|
Chairman | 51 | 12.02.20 | |
Mohammad Shafiq
CEO | Chief Executive Officer | 63 | 25.11.20 |
Director/Board Member | 44 | 25.11.20 | |
Director of Finance/CFO | 54 | 25.11.20 | |
Sayeed Ahmed
BRD | Director/Board Member | 46 | 25.11.20 |
Zahara Rasul
BRD | Director/Board Member | 50 | 25.11.20 |
Tarana Ahmed
BRD | Director/Board Member | 45 | 25.11.20 |
Masuma Parvin
BRD | Director/Board Member | 56 | 25.12.20 |
Director/Board Member | 57 | 06.09.21 | |
Director/Board Member | 41 | 06.09.21 |
Anteilsklasse
Vote | Menge | Streubesitz | Konzerneigene Aktien | Total Float | |
---|---|---|---|---|---|
Aktie A | 1 | 107 416 217 | 106 342 055 ( 99,00 %) | 0 | 99,00 % |
Unternehmenskontakt
![Straße Navana Pharmaceuticals PLC(NAVANAPHAR)](https://cdn.zonebourse.com/static/address/145512643.png)
Sektor
Umsatz nach Geschäftsbereich
% 1. Jan. | Kap. | |
---|---|---|
+6.16% | 81.91 Mio. | |
+55.32% | 815 Mrd. | |
-6.75% | 352 Mrd. | |
+13.56% | 314 Mrd. | |
+10.68% | 303 Mrd. | |
+16.57% | 242 Mrd. | |
+2.04% | 224 Mrd. | |
+13.31% | 218 Mrd. | |
+8.48% | 168 Mrd. | |
-2.81% | 159 Mrd. |
- Börse
- Aktien
- NAVANAPHAR Aktie
- Unternehmen Navana Pharmaceuticals PLC